Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2020-11-12 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
UK-RTC Statement
Regulatory Filings Classification · 1% confidence The document is a press release issued via the RNS (Regulatory News Service) platform by Omega Diagnostics Group PLC. It addresses specific press speculation and a BMJ research report regarding the company's AbC-19 Rapid Test. It functions as a corporate statement to clarify the company's position and defend its product performance. Since it does not fit into specific categories like financial reports, board changes, or dividend announcements, and is a general regulatory/corporate announcement, it is classified as an RNS.
2020-11-12 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for a specific security. It does not contain financial results, governance reports, or corporate strategy, but rather a technical market announcement regarding trading parameters. As it is a regulatory announcement that does not fit into specific categories like M&A or dividends, it falls under the RNS fallback category.
2020-11-12 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard automated market notice regarding trading parameters rather than a financial report, management update, or corporate action. As it does not fit into specific categories like dividends, M&A, or director dealings, it falls under the RNS (Regulatory Filings) category.
2020-11-12 English
Response to media comment
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement (RNS) issued by Omega Diagnostics Group PLC regarding a response to media comments about their AbC-19 Rapid Test. It does not constitute a formal financial report, audit, or proxy statement. As it is a general regulatory announcement that does not fit into the specific categories like M&A, dividends, or share issues, it falls under the fallback category of Regulatory Filings (RNS).
2020-11-12 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short, automated notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Second Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard market regulatory announcement regarding trading parameters and does not constitute a financial report, dividend notice, or management update. As it is a general regulatory announcement that does not fit into the specific categories provided, it falls under the RNS fallback category.
2020-11-12 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short, automated notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for Omega Diagnostics Group PLC. It does not contain financial results, management reports, or corporate governance details, but rather serves as a standard regulatory market notice. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the fallback category for general regulatory announcements.
2020-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.